Lv1
30 积分 2024-11-18 加入
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study
1天前
已完结
How safe are proprotein convertase subtilisinekexin type 9 inhibitors in diabetes
1天前
已完结
Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies in Regard to Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
1天前
已完结
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
1天前
已完结
Noncoding RNAs in atherosclerosis
3个月前
已完结
The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis
3个月前
已完结
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
3个月前
已完结
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis
3个月前
已完结
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)
3个月前
已完结
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
3个月前
已完结
皖公网安备34019202002308
